ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 42 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 1,300 | +56.4% | 0.00% | – |
| Q3 2018 | $2,000 | -100.0% | 831 | -99.9% | 0.00% | -100.0% |
| Q1 2017 | $9,076,000 | +17.4% | 985,438 | -1.8% | 0.00% | 0.0% |
| Q4 2016 | $7,734,000 | -25.7% | 1,003,138 | +10.1% | 0.00% | 0.0% |
| Q3 2016 | $10,416,000 | -7.1% | 911,303 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $11,218,000 | +21.8% | 911,303 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $9,213,000 | -62.0% | 911,303 | -15.3% | 0.00% | -66.7% |
| Q4 2015 | $24,263,000 | +63.7% | 1,076,420 | +20.5% | 0.00% | +50.0% |
| Q3 2015 | $14,826,000 | -23.1% | 893,664 | +4.3% | 0.00% | 0.0% |
| Q2 2015 | $19,284,000 | -12.2% | 857,066 | +0.6% | 0.00% | -33.3% |
| Q1 2015 | $21,974,000 | +18.5% | 852,366 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $18,547,000 | +14.9% | 852,366 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $16,135,000 | -18.8% | 852,366 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $19,860,000 | +204.1% | 852,366 | +339.1% | 0.00% | +200.0% |
| Q1 2014 | $6,531,000 | +14.0% | 194,100 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $5,730,000 | +92.8% | 194,100 | 0.0% | 0.00% | – |
| Q3 2013 | $2,972,000 | – | 194,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|